01 Record
CVE-2015-3965
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly
UnratedPUBLISHEDCNA: icscert
CNA base scoreUnratedNo CNA CVSS vector
02 Description
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly
03 Exploitation and scoring
- Exploitation
- Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
- SSVC decision
- Not assessed by CISA
- EPSS probability
- 2.88% probability of exploitation activity in the next 30 days.
- EPSS percentile
- Equal to or higher than the score of 86.7% of scored records. A rank, not a probability.
- NVD base score
- 8.8 (CVSS v3.x), scored by the NVD independently of the CNA.
- NVD CVSS vector
- CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- NVD analysis status
- Modified. NVD last modified this record on 2026-06-17.
- Red Hat severity
- No Red Hat rating. Red Hat rates the CVEs that affect its products.
Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.
04 Metadata
- Published
- 2019-03-23 19:23Z7 YR AGO
- Last updated
- 2024-08-06 06:04Z2 YR AGO
- Reserved
- 2015-05-12
- Assigning CNA
- icscert
- Record state
- PUBLISHED
- Severity
- Not rated by the issuing CNA
- CNA CVSS vector
- Not published by the issuing CNA
- Weaknesses
- Data version
- 5.1
- Document digest
- 786c5a8160aed80f594f546b42f07769bd280e7fc759acd1676f58de1e87d2b0
05 Affected products
VendorProductVersionsPlatforms
06 References
- ics-cert.us-cert.govhttps://ics-cert.us-cert.gov/advisories/ICSA-15-174-01